Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prognostic accuracy of MALDI mass spectrometric analysis of plasma in COVID-19

Lucas Cardoso Lazari, Fabio De Rose Ghilardi, Livia Rosa-Fernandes, Diego M Assis, José Carlos Nicolau, Veronica Feijoli Santiago, Talia Falcão Dalçóquio, Claudia B. Angeli, Adriadne Justi Bertolin, Claudio R. F. Marinho, Carsten Wrenger, Edison Luiz Durigon, Rinaldo Focaccia Siciliano, View ORCID ProfileGiuseppe Palmisano
doi: https://doi.org/10.1101/2020.10.01.20205310
Lucas Cardoso Lazari
1Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabio De Rose Ghilardi
2Instituto de Medicina Tropical, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Livia Rosa-Fernandes
1Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diego M Assis
3Bruker do Brasil, Atibaia, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Carlos Nicolau
4Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronica Feijoli Santiago
1Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Talia Falcão Dalçóquio
4Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia B. Angeli
1Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriadne Justi Bertolin
4Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio R. F. Marinho
1Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carsten Wrenger
1Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edison Luiz Durigon
5Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rinaldo Focaccia Siciliano
4Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuseppe Palmisano
1Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giuseppe Palmisano
  • For correspondence: palmisano.gp@gmail.com palmisano.gp@usp.br
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose SARS-CoV-2 infection poses a global public health problem. There is a critical need for improvements in the noninvasive prognosis of COVID-19. We hypothesized that matrix-assisted laser desorption ionization mass spectrometry (MALDI-TOF MS) analysis combined with bottom-up proteomic analysis of plasma proteins might identify features to predict high and low risk cases of COVID-19.

Patients and Methods We used MALDI-TOF MS to analyze plasma small proteins and peptides isolated using C18 micro-columns from a cohort containing a total of 117 cases of high (hospitalized) and low risk (outpatients) cases split into training (n = 88) and validation sets (n= 29). The plasma protein/peptide fingerprint obtained was used to train the algorithm before validation using a blinded test cohort.

Results Several sample preparation, MS and data analysis parameters were optimized to achieve an overall accuracy of 85%, sensitivity of 90%, and specificity of 81% in the training set. In the blinded test set, this signature reached an overall accuracy of 93.1%, sensitivity of 87.5%, and specificity of 100%. From this signature, we identified two distinct regions in the MALDI-TOF profile belonging to the same proteoforms. A combination of 1D SDS-PAGE and quantitative bottom-up proteomic analysis allowed the identification of intact and truncated forms of serum amyloid A-1 and A-2 proteins. Conclusions: We found a plasma proteomic profile that discriminates against patients with high and low risk COVID-19. Proteomic analysis of C18-fractionated plasma may have a role in the noninvasive prognosis of COVID-19. Further validation will consolidate its clinical utility.

What is the key question?Do individuals infected with SARS-CoV-2 harboring different degree of disease severity have a plasma protein profile that differentiate them and predict the COVID-19 outcome?

What is the bottom line?In a series of 117 patients with COVID-19 divided in hospitalized (60) and outpatients (57), differential expression of serum amyloid A-1 (SAA1) and A-2 (SAA2) predict their outcome.

Why read on?The high mortality rate in SARS-CoV-2 infected individuals requires accurate markers for predicting COVID-19 severity. Plasma levels of SAA1 and SAA2 indicate higher risk of hospitalization and can be used to improve COVID-19 monitoring and therapy.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by FAPESP, GP (2018/18257-1, 2018/15549-1, 2020/04923-0), CW (2015/26722-8, 2017/03966-4), CRFM (2018/20468-0) and JCN (2020/04705-2). GP, CW, and CRFM were supported by CNPq.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Plasma from a total of 117 patients with COVID-19 divided into high risk (n = 57) and low risk (n = 60) was collected prospectively from a Brazilian cohort at the Heart Institute (InCor) and Central Institute, University of Sao Paulo Medical School, Brazil, between March 2020 to July 2020. The study was appproved by the COMISSAO NACIONAL DE ETICA EM PESQUISA (CAAE 30299620.7.0000.0068 ).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Raw data were submitted to PRIDE (https://www.ebi.ac.uk/pride/), project number PXD021581.

  • Abbreviations

    (ACN)
    Acetonitrile
    (HCCA)
    Alpha-cyano-hydroxycinnamic acid
    (AUC)
    Area under curve
    (CV)
    Coefficient of variance
    (COVID-19)
    Coronavirus disease 2019
    (CRP)
    C-reactive protein
    (DHB)
    Dihydroxybenzoic acid
    (EDTA)
    Ethylenediamine tetra acetic acid
    (IQR)
    Interquartile range
    (MALDI-TOF MS)
    Matrix-assisted laser desorption ionization mass spectrometry
    (PR)
    Precision-recall curve
    (ROC)
    Receiver operating characteristic curve
    (SAA)
    Serum amyloid A1/A2
    (SA)
    Sinapinic acid
    (SDS-PAGE)
    Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
    (TFA)
    Trifluoroacetic acid
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted October 04, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Prognostic accuracy of MALDI mass spectrometric analysis of plasma in COVID-19
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Prognostic accuracy of MALDI mass spectrometric analysis of plasma in COVID-19
    Lucas Cardoso Lazari, Fabio De Rose Ghilardi, Livia Rosa-Fernandes, Diego M Assis, José Carlos Nicolau, Veronica Feijoli Santiago, Talia Falcão Dalçóquio, Claudia B. Angeli, Adriadne Justi Bertolin, Claudio R. F. Marinho, Carsten Wrenger, Edison Luiz Durigon, Rinaldo Focaccia Siciliano, Giuseppe Palmisano
    medRxiv 2020.10.01.20205310; doi: https://doi.org/10.1101/2020.10.01.20205310
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Prognostic accuracy of MALDI mass spectrometric analysis of plasma in COVID-19
    Lucas Cardoso Lazari, Fabio De Rose Ghilardi, Livia Rosa-Fernandes, Diego M Assis, José Carlos Nicolau, Veronica Feijoli Santiago, Talia Falcão Dalçóquio, Claudia B. Angeli, Adriadne Justi Bertolin, Claudio R. F. Marinho, Carsten Wrenger, Edison Luiz Durigon, Rinaldo Focaccia Siciliano, Giuseppe Palmisano
    medRxiv 2020.10.01.20205310; doi: https://doi.org/10.1101/2020.10.01.20205310

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (62)
    • Allergy and Immunology (142)
    • Anesthesia (46)
    • Cardiovascular Medicine (415)
    • Dentistry and Oral Medicine (70)
    • Dermatology (47)
    • Emergency Medicine (144)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
    • Epidemiology (4855)
    • Forensic Medicine (3)
    • Gastroenterology (183)
    • Genetic and Genomic Medicine (676)
    • Geriatric Medicine (70)
    • Health Economics (192)
    • Health Informatics (628)
    • Health Policy (320)
    • Health Systems and Quality Improvement (203)
    • Hematology (85)
    • HIV/AIDS (156)
    • Infectious Diseases (except HIV/AIDS) (5339)
    • Intensive Care and Critical Care Medicine (330)
    • Medical Education (93)
    • Medical Ethics (24)
    • Nephrology (75)
    • Neurology (686)
    • Nursing (42)
    • Nutrition (115)
    • Obstetrics and Gynecology (126)
    • Occupational and Environmental Health (208)
    • Oncology (439)
    • Ophthalmology (140)
    • Orthopedics (36)
    • Otolaryngology (89)
    • Pain Medicine (35)
    • Palliative Medicine (16)
    • Pathology (129)
    • Pediatrics (194)
    • Pharmacology and Therapeutics (131)
    • Primary Care Research (84)
    • Psychiatry and Clinical Psychology (780)
    • Public and Global Health (1816)
    • Radiology and Imaging (324)
    • Rehabilitation Medicine and Physical Therapy (138)
    • Respiratory Medicine (255)
    • Rheumatology (86)
    • Sexual and Reproductive Health (69)
    • Sports Medicine (62)
    • Surgery (100)
    • Toxicology (23)
    • Transplantation (29)
    • Urology (37)